CN Patent

CN104860923B — 富马酸沃诺拉赞的制备方法

Assigned to Shandong Kang Meile Pharmaceutical Technology Co Ltd · Expires 2018-01-12 · 8y expired

What this patent protects

本发明涉及药物制备研究领域，特别涉及1‑[5‑(2‑氟苯基)‑1‑(吡啶‑3‑基磺酰基)‑1H‑吡咯‑3‑基]‑N‑甲基甲胺富马酸盐（式Ⅰ）及其中间体的一种制备方法。该方法特征在于以式（Ⅴ）化合物为重要中间体，通过氮单甲基化，成盐制备式（Ⅰ）化合物。式（Ⅴ）化合物结构式为 ，式（Ⅰ）化合物结构式为 。

USPTO Abstract

本发明涉及药物制备研究领域，特别涉及1‑[5‑(2‑氟苯基)‑1‑(吡啶‑3‑基磺酰基)‑1H‑吡咯‑3‑基]‑N‑甲基甲胺富马酸盐（式Ⅰ）及其中间体的一种制备方法。该方法特征在于以式（Ⅴ）化合物为重要中间体，通过氮单甲基化，成盐制备式（Ⅰ）化合物。式（Ⅴ）化合物结构式为 ，式（Ⅰ）化合物结构式为 。

Drugs covered by this patent

Patent Metadata

Patent number
CN104860923B
Jurisdiction
CN
Classification
—
Expires
2018-01-12
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Kang Meile Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.